Cargando…
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for Real-Time Pandemic Surveillance
BACKGROUND: Population-based seroprevalence studies offer comprehensive characterization of coronavirus disease 2019 (COVID-19) spread, but barriers exist and marginalized populations may not be captured. We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody seroprevalenc...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995069/ https://www.ncbi.nlm.nih.gov/pubmed/35415200 http://dx.doi.org/10.1093/ofid/ofac142 |
_version_ | 1784684238042300416 |
---|---|
author | Coburn, Sally B Manabe, Yukari C Laeyendecker, Oliver Sherman, Susan G Baker, Owen R Quinn, Thomas C Graham, Lindsey A Dennis Thomas, F Southall, Pamela Weedn, Victor W Ehsani, Johnathon Klock, Ethan Li, Rong Shields, Wendy C Michael, Jeffrey Paul Li, Ling Althoff, Keri N |
author_facet | Coburn, Sally B Manabe, Yukari C Laeyendecker, Oliver Sherman, Susan G Baker, Owen R Quinn, Thomas C Graham, Lindsey A Dennis Thomas, F Southall, Pamela Weedn, Victor W Ehsani, Johnathon Klock, Ethan Li, Rong Shields, Wendy C Michael, Jeffrey Paul Li, Ling Althoff, Keri N |
author_sort | Coburn, Sally B |
collection | PubMed |
description | BACKGROUND: Population-based seroprevalence studies offer comprehensive characterization of coronavirus disease 2019 (COVID-19) spread, but barriers exist and marginalized populations may not be captured. We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody seroprevalence among decedents in Maryland over 6 months in 2020. METHODS: Data were collected on decedents undergoing forensic postmortem examination in Maryland from 24 May through 30 November 2020 from whom a blood specimen could be collected. Those with available blood specimens were tested with the CoronaCHEK lateral flow antibody assay. We assessed monthly seroprevalence compared to the statewide estimated number of cases and proportion of positive test results (testing positivity). We used Poisson regression with robust variance to estimate adjusted prevalence ratios (aPRs) with 95% confidence intervals (CIs) for associations of demographic characteristics, homelessness, and manner of death with SARS-CoV-2 antibodies. RESULTS: Among 1906 decedents, 305 (16%) were positive for SARS-CoV-2 antibodies. Monthly seroprevalence increased from 11% to 22% over time and was consistently higher than state-level estimates of testing positivity. Hispanic ethnicity was associated with 2- to 3.2-fold higher seropositivity (P < .05) irrespective of sex. Deaths due to motor vehicle crash were associated with 62% increased seropositivity (aPR, 1.62 [95% CI, 1.15–2.28]) vs natural manner of death. Though seroprevalence was lower in decedents of illicit drug overdose vs nonoverdose in early months, this shifted, and seroprevalence was comparable by November 2020. CONCLUSIONS: Decedents undergoing forensic postmortem examination, especially those dying due to motor vehicle trauma, may be a sentinel population for COVID-19 spread in the general population and merits exploration in other states/regions. |
format | Online Article Text |
id | pubmed-8995069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89950692022-04-11 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for
Real-Time Pandemic Surveillance Coburn, Sally B Manabe, Yukari C Laeyendecker, Oliver Sherman, Susan G Baker, Owen R Quinn, Thomas C Graham, Lindsey A Dennis Thomas, F Southall, Pamela Weedn, Victor W Ehsani, Johnathon Klock, Ethan Li, Rong Shields, Wendy C Michael, Jeffrey Paul Li, Ling Althoff, Keri N Open Forum Infect Dis Major Article BACKGROUND: Population-based seroprevalence studies offer comprehensive characterization of coronavirus disease 2019 (COVID-19) spread, but barriers exist and marginalized populations may not be captured. We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody seroprevalence among decedents in Maryland over 6 months in 2020. METHODS: Data were collected on decedents undergoing forensic postmortem examination in Maryland from 24 May through 30 November 2020 from whom a blood specimen could be collected. Those with available blood specimens were tested with the CoronaCHEK lateral flow antibody assay. We assessed monthly seroprevalence compared to the statewide estimated number of cases and proportion of positive test results (testing positivity). We used Poisson regression with robust variance to estimate adjusted prevalence ratios (aPRs) with 95% confidence intervals (CIs) for associations of demographic characteristics, homelessness, and manner of death with SARS-CoV-2 antibodies. RESULTS: Among 1906 decedents, 305 (16%) were positive for SARS-CoV-2 antibodies. Monthly seroprevalence increased from 11% to 22% over time and was consistently higher than state-level estimates of testing positivity. Hispanic ethnicity was associated with 2- to 3.2-fold higher seropositivity (P < .05) irrespective of sex. Deaths due to motor vehicle crash were associated with 62% increased seropositivity (aPR, 1.62 [95% CI, 1.15–2.28]) vs natural manner of death. Though seroprevalence was lower in decedents of illicit drug overdose vs nonoverdose in early months, this shifted, and seroprevalence was comparable by November 2020. CONCLUSIONS: Decedents undergoing forensic postmortem examination, especially those dying due to motor vehicle trauma, may be a sentinel population for COVID-19 spread in the general population and merits exploration in other states/regions. Oxford University Press 2022-04-10 /pmc/articles/PMC8995069/ /pubmed/35415200 http://dx.doi.org/10.1093/ofid/ofac142 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Coburn, Sally B Manabe, Yukari C Laeyendecker, Oliver Sherman, Susan G Baker, Owen R Quinn, Thomas C Graham, Lindsey A Dennis Thomas, F Southall, Pamela Weedn, Victor W Ehsani, Johnathon Klock, Ethan Li, Rong Shields, Wendy C Michael, Jeffrey Paul Li, Ling Althoff, Keri N Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for Real-Time Pandemic Surveillance |
title | Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for
Real-Time Pandemic Surveillance |
title_full | Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for
Real-Time Pandemic Surveillance |
title_fullStr | Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for
Real-Time Pandemic Surveillance |
title_full_unstemmed | Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for
Real-Time Pandemic Surveillance |
title_short | Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for
Real-Time Pandemic Surveillance |
title_sort | severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in decedents undergoing forensic postmortem examination: feasibility for
real-time pandemic surveillance |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995069/ https://www.ncbi.nlm.nih.gov/pubmed/35415200 http://dx.doi.org/10.1093/ofid/ofac142 |
work_keys_str_mv | AT coburnsallyb severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT manabeyukaric severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT laeyendeckeroliver severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT shermansusang severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT bakerowenr severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT quinnthomasc severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT grahamlindseya severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT dennisthomasf severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT southallpamela severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT weednvictorw severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT ehsanijohnathon severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT klockethan severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT lirong severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT shieldswendyc severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT michaeljeffreypaul severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT liling severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance AT althoffkerin severeacuterespiratorysyndromecoronavirus2antibodyseroprevalenceindecedentsundergoingforensicpostmortemexaminationfeasibilityforrealtimepandemicsurveillance |